Imposing RCTs For Supplement Claims Would Cause 'Wholesale Change' In Regulation – CRN, CHPA

“The industry would face confusion as to the appropriate substantiation standard for non-disease dietary supplement claims,” say the Council for Responsible Nutrition and the Consumer Healthcare Products Association in a joint amicus brief filed with in Second Circuit. They submitted the brief in support of Quincy’s motion urging the appeals court to dismiss an appeal by FTC and New York of a federal district court’s 2017 dismissal of the federal and state agencies' complaint against Quincy.

Requiring clinical testing for drugs to support a dietary supplement claim would cause a “wholesale change” in the substantiation standard for supplements, industry trade groups argue in support of dismissing a Federal Trade Commission complaint against [Quincy Bioscience LLC].

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Legal

More from Policy & Regulation